CAR-T cell therapy is a newer treatment option for myeloma that helps your immune system fight cancer cells more effectively. Here's how it works:
• Your T cells (immune cells) are collected through a process called apheresis
• These cells are genetically modified in a lab
• The modified cells are then returned to your Show Full Answer
CAR-T cell therapy is a newer treatment option for myeloma that helps your immune system fight cancer cells more effectively. Here's how it works:
• Your T cells (immune cells) are collected through a process called apheresis
• These cells are genetically modified in a lab
• The modified cells are then returned to your body
• These enhanced T cells can now recognize and attack myeloma cells To qualify for CAR-T therapy, you need to have:
• Myeloma that is refractory (resistant to treatment) or has relapsed
• Tried at least four other treatments including:
- Immunomodulatory drugs
- Proteasome inhibitors
- Anti-CD38 monoclonal antibodies
The treatment success rates are encouraging:
• 75% of patients show reduced cancer signs
• 33% achieve complete response
• Of those with complete response, 66% maintain remission for at least a year Important considerations:
• Treatment is only available at certified locations with specially trained staff
• You'll need to stay in hospital during treatment
• Plan to remain close to the treatment center for about a month after discharge for monitoring
• While side effects are common, most are mild and manageable with proper care
September 18, 2025
Join
Your Privacy Choices
